Label: WAL-ZAN- ranitidine hydrochloride tablets 150mg tablet, coated

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated September 30, 2019

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Ranitidine 150 mg (as ranitidine hydrochloride USP, 168 mg)

  • Purpose

    Acid reducer

  • Use(s)

    • relieves heartburn associated with acid indigestion and sour stomach
    • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
  • Warnings

    Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

    Do not use

    • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
    • with other acid reducers
    • if you have kidney disease, except under the advice and supervision of a doctor

    Ask a doctor before use if you have

    • had heartburn over 3 months. This may be a sign of a more serious condition.
    • heartburn with lightheadedness, sweating or dizziness
    • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
    • frequent chest pain
    • frequent wheezing, particularly with heartburn
    • unexplained weight loss
    • nausea or vomiting
    • stomach pain

    Stop use and ask doctor if

    • your heartburn continues or worsens
    • you need to take this product for more than 14 days

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults and children 12 years and over:
      • to relieve symptoms, swallow 1 tablet with a glass of water
      • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
      • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
    • children under 12 years: ask a doctor
  • Other information

    • do not use if printed foil under bottle cap is open or torn
    • store at 20°-25°C (68°-77°F)
    • avoid excessive heat or humidity
    • protect from light
    • this product is sodium and sugar free
  • Inactive ingredients

    FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

  • Questions

    call 1-888-375-3784

    TAMPER EVIDENT: DO NOT USE IF FOIL SEAL UNDER CAP PRINTED WITH "SEALED FOR YOUR PROTECTION" IS BROKEN OR MISSING

    IMPORTANT: Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

  • container label

    carton

  • INGREDIENTS AND APPEARANCE
    WAL-ZAN 
    ranitidine hydrochloride tablets 150mg tablet, coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0363-0010(NDC:55111-404)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RANITIDINE HYDROCHLORIDE (UNII: BK76465IHM) (RANITIDINE - UNII:884KT10YB7) RANITIDINE150 mg
    Inactive Ingredients
    Ingredient NameStrength
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    magnesium stearate (UNII: 70097M6I30)  
    cellulose, microcrystalline (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorPINKScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code R150
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0363-0010-341 in 1 CARTON06/11/201109/30/2019
    124 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:0363-0010-501 in 1 CARTON06/11/201109/30/2019
    250 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:0363-0010-621 in 1 CARTON06/11/201109/30/2019
    395 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:0363-0010-321 in 1 CARTON06/11/201109/30/2019
    432 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:0363-0010-011 in 1 CARTON06/11/201109/30/2019
    5200 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:0363-0010-231 in 1 CARTON06/11/201109/30/2019
    636 in 1 BOTTLE; Type 0: Not a Combination Product
    7NDC:0363-0010-261 in 1 CARTON06/11/201109/30/2019
    765 in 1 BOTTLE; Type 0: Not a Combination Product
    8NDC:0363-0010-611 in 1 CARTON06/11/201109/30/2019
    865 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07819206/11/2011
    Labeler - Walgreens Company (008965063)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!